Wall Street stories

Aug 11, 2026

Cardinal Health raises full-year profit forecast on specialty drug strength

U.S. drug distributor Cardinal Health forecast fiscal 2027 profit well above Wall Street expectations after beating fourth-quarter estimates, driven by sustained demand for specialty drugs.

Aug 11, 20262 sources

Aug 5, 2026

Hedge funds targeted in wave of sophisticated cyberattacks

Hackers launched coordinated attacks on Wall Street firms in recent days, primarily targeting hedge fund information systems.

Aug 5, 20262 sources

Aug 3, 2026

Palantir raises full-year forecast after US commercial revenue surges 150%

Palantir Technologies reported second-quarter sales far exceeding Wall Street estimates and raised its full-year revenue and income forecasts, with US commercial revenue more than doubling year-over-year. The stock surged 12% following the announcement.

Aug 3, 20262 sources

Jul 30, 2026

Coinbase posts $359 million Q2 loss on $1.22 billion revenue, missing Wall Street estimates

Coinbase reported a $359 million net loss for Q2 2026 on revenue of $1.22 billion, below the $1.29 billion consensus. This marks the company's third consecutive quarterly loss as crypto trading activity slowed, though prediction markets revenue doubled and trading market share hit a record 10.3%.

Jul 30, 202612 sources

Jul 23, 2026

Intel forecast tops estimates as AI boom boosts data center demand

Intel's quarterly revenue forecast shattered Wall Street estimates, with the company raising spending plans over the next two years as data center growth accelerates. Revenue rose 25% in Q2, the fastest growth in 15 years.

Jul 23, 20263 sources

Jul 15, 2026

Johnson & Johnson beats earnings estimates on strength of Tremfya and Darzalex

Johnson & Johnson exceeded Wall Street estimates for second-quarter sales and profit, driven by strong demand for immunology drug Tremfya and cancer treatment Darzalex, offsetting erosion in other product lines.

Jul 15, 20261 source

May 4, 2026

Anthropic Finalizes $1.5 Billion Joint Venture with Blackstone and Goldman Sachs for Enterprise AI

Anthropic is closing a $1.5 billion joint venture with Blackstone, Goldman Sachs, and other Wall Street firms to sell AI tools to private-equity-backed companies. OpenAI is launching a similar enterprise-focused joint venture with asset managers.

May 4, 20263 sources